ENvue Medical Seeks Stockholder Approval for Reverse Stock Split to Avoid Nasdaq Delisting
FEED is trading near its 52-week low of $0.422 (11% above the low) on light trading volume (0.2× avg).
Summary
ENvue Medical calls a special stockholder meeting for August 14, 2026 to vote on a reverse stock split aimed at regaining Nasdaq compliance after receiving a delisting notice. The company faces immediate delisting risk because prior reverse splits disqualify it from the standard grace period.
Key Events · Corporate Governance and Compliance · FEED
-
Reverse Stock Split Proposed
Board seeks approval for a reverse stock split at a ratio between 1-for-2 and 1-for-50 to increase the stock price above $1.00 and regain Nasdaq compliance. The special meeting is set for August 14, 2026.
-
Nasdaq Delisting Notice
On July 10, 2026, Nasdaq notified the company that its stock had closed below $1.00 for 30 consecutive business days. The company is not eligible for the standard 180-day compliance period because it has already executed two reverse splits in the past year.
-
Third Reverse Split in 18 Months
The company previously executed a 1-for-11 reverse split on March 13, 2025 and a 1-for-10 reverse split on August 12, 2025. The cumulative ratio of prior splits is 1-for-110, and the new split could push the total above the 250-to-one threshold, triggering immediate delisting if the price falls below $1 again.
-
Appeal to Stay Delisting
The company intends to request a hearing before Nasdaq's Appeal Panel, which will stay any suspension or delisting action pending the panel's decision. There is no assurance the appeal will be successful.
Analysis · FEED · Industrial Applications And Services
ENvue Medical is fighting to stay on Nasdaq after receiving a delisting notice on July 10, 2026. The company is asking stockholders to approve a reverse stock split at a ratio between 1-for-2 and 1-for-50 at a special meeting on August 14, 2026. This is the third reverse split in 18 months — the company already executed a 1-for-11 split in March 2025 and a 1-for-10 split in August 2025. Because of those prior splits, Nasdaq has denied the standard 180-day compliance period, meaning the stock faces immediate delisting unless the split boosts the price above $1. The company will also appeal the delisting determination, which stays any suspension pending a hearing. With the stock at $0.47 and a market cap of just $2.8 million, the reverse split is a last-ditch effort to preserve the Nasdaq listing, which is critical for liquidity and access to capital.
How filings like this one have moved
In the 30 days to Sep 11, 2026, 42.4% of the 517 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.47%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FEED was trading at $0.47 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.8M. The 52-week trading range was $0.42 to $17.40. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.